Confronto

Linaclotid vs. Sincalide

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

851199-59-2

25126-32-3

Peso molecolare

1526.74 g/mol

1143.29 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Meccanismo d'azione

Linaclotid

Linaclotide activates the guanylate cyclase-C receptor on the luminal surface of the intestinal epithelium. This raises cyclic GMP (cGMP), increases secretion of chloride and bicarbonate into the lumen, raises stool fluid content and accelerates transit; pain signaling is also modulated.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Linaclotid	Sincalide
Germania	Su prescrizione	Non chiaro
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Linaclotid and Sincalide?: Linaclotid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Linaclotid or Sincalide?: The highest available evidence level is "RCT sull'uomo" for Linaclotid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Linaclotid and Sincalide in Germany and the United States?: Germania: Linaclotid — Su prescrizione, Sincalide — Non chiaro. Stati Uniti: Linaclotid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Linaclotid

Sincalide

Germania

Su prescrizione

Non chiaro

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Linaclotid and Sincalide?

Linaclotid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Linaclotid: Linaclotide is a 14-amino-acid peptide and guanylate cyclase-C (GC-C) agonist. It is approved for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Linaclotid or Sincalide?

The highest available evidence level is "RCT sull'uomo" for Linaclotid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Linaclotid and Sincalide in Germany and the United States?

Germania: Linaclotid — Su prescrizione, Sincalide — Non chiaro. Stati Uniti: Linaclotid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.